Disease details

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01854359 (ClinicalTrials.gov)	May 11, 2013	11/5/2013	Idebenone for Primary Progressive Multiple Sclerosis	Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis	Multiple Sclerosis;Primary Progressive Multiple Sclerosis	Drug: Idebenone	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Unknown status	18 Years	N/A	All	61	Phase 1/Phase 2	United States
2	NCT00950248 (ClinicalTrials.gov)	November 1, 2009	30/7/2009	Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS)	Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis	Primary Progressive Multiple Sclerosis	Drug: Idebenone;Other: placebo	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	65 Years	All	85	Phase 1/Phase 2	United States